الفهرس 
cover EnglishOnly 14 pages are availabe for public view
 |  | from | 132 |  |  |
| | | from | 132 | | |
Abstract
Down Syndrome Has Been Recognized As One Of The Most Important Leukemia Predisposing Syndromes And Patients With Down Syndrome And Leukemia Have Unique Clinical Features And Significant Differences In Treatment Response And Toxicity Profiles. One Of The Challenges Faced In Treating Children With Down Syndrome And Leukemia Is Balancing Curative Therapy Against Potential Toxicities.